Skip to main content
Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)
Italy flag Italy · Delayed Price · Currency is EUR
49.82
+0.06 (0.12%)
Apr 28, 2026, 5:37 PM CET

BIT:REC Revenue

In the year 2025, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.62B EUR with 11.82% growth. Recordati Industria Chimica e Farmaceutica had revenue of 662.22M in the quarter ending December 31, 2025, with 10.65% growth.

Revenue
2.62B
Revenue Growth
+11.82%
P/S Ratio
3.89
Revenue / Employee
562.61K
Employees
4,693
Market Cap
10.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.62B276.82M11.82%
Dec 31, 20242.34B259.23M12.45%
Dec 31, 20232.08B229.02M12.36%
Dec 31, 20221.85B273.23M17.29%
Dec 31, 20211.58B131.21M9.06%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DiaSorin 1.20B
Amplifon 2.40B
EL.En. 590.85M
Philogen 319.73M
Pharmanutra 132.16M
Safilo Group 983.38M
GPI S.p.A. 546.18M
Garofalo Health Care 485.12M
Revenue Rankings

Recordati Industria Chimica e Farmaceutica News

More News